Clinical Trials
3 trialsNCT03127449 2025-04-03
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Allist Pharmaceuticals, Inc.
Phase NA Terminated
NCT06752044 2024-12-30
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
The First Affiliated Hospital of Nanchang University
Phase NA Recruiting
NCT06752057 2024-12-30
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
The First Affiliated Hospital of Nanchang University
Phase NA Recruiting